| Table 3.2 Clients in treatment, by type of care received and clients receiving methadone or buprenorphine: 2004-20081 Number and percent distribution |
||||||||||
| Type of care received and clients
receiving methadone or buprenorphine |
Number of clients | Percent distribution | ||||||||
| 2004 | 2005 | 2006 | 2007 | 2008 | 2004 | 2005 | 2006 | 2007 | 2008 | |
| Total | 1,072,251 | 1,081,049 | 1,130,881 | 1,135,425 | 1,192,490 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Type of care received | ||||||||||
| Outpatient | 954,551 | 961,805 | 1,008,915 | 1,016,913 | 1,071,572 | 89.0 | 89.0 | 89.2 | 89.6 | 89.9 |
| Regular | 564,300 | 569,272 | 589,542 | 595,459 | 644,009 | 52.6 | 52.7 | 52.1 | 52.4 | 54.0 |
| Intensive | 121,862 | 125,573 | 128,706 | 132,977 | 130,260 | 11.4 | 11.6 | 11.4 | 11.7 | 10.9 |
| Detoxification | 12,064 | 13,474 | 12,579 | 12,705 | 11,339 | 1.1 | 1.2 | 1.1 | 1.1 | 1.0 |
| Day treatment/partial hospitalization | 28,133 | 24,928 | 24,039 | 22,297 | 22,835 | 2.6 | 2.3 | 2.1 | 2.0 | 1.9 |
| Methadone/buprenorphine maintenance | 228,192 | 228,558 | 254,049 | 253,475 | 263,129 | 21.3 | 21.1 | 22.5 | 22.3 | 22.1 |
| Residential (non-hospital) | 101,713 | 104,015 | 107,790 | 103,709 | 107,441 | 9.5 | 9.6 | 9.5 | 9.1 | 9.0 |
| Detoxification | 7,021 | 7,306 | 6,487 | 7,536 | 6,746 | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 |
| Short-term treatment (30 days or fewer) | 21,758 | 23,360 | 22,234 | 24,171 | 25,566 | 2.0 | 2.2 | 2.0 | 2.1 | 2.1 |
| Long-term treatment (more than 30 days) | 72,934 | 73,349 | 79,069 | 72,002 | 75,129 | 6.8 | 6.8 | 7.0 | 6.3 | 6.3 |
| Hospital inpatient | 15,987 | 15,229 | 14,176 | 14,803 | 13,477 | 1.5 | 1.4 | 1.3 | 1.3 | 1.1 |
| Detoxification | 6,214 | 6,381 | 5,220 | 6,319 | 5,686 | 0.6 | 0.6 | 0.5 | 0.6 | 0.5 |
| Treatment | 9,773 | 8,848 | 8,956 | 8,484 | 7,791 | 0.9 | 0.8 | 0.8 | 0.7 | 0.7 |
| Clients receiving methadone or buprenorphine | ||||||||||
| Total | 243,358 | 240,935 | 265,786 | 266,031 | 283,803 | 22.7 | 22.3 | 23.5 | 23.4 | 23.8 |
| Clients receiving methadone | 240,961 | 235,836 | 258,752 | 262,684 | 268,071 | 22.5 | 21.8 | 22.9 | 23.1 | 22.5 |
| Clients receiving buprenorphine | 2,397 | 5,099 | 7,034 | 3,347 | 15,732 | 0.2 | 0.5 | 0.6 | 0.3 | 1.3 |
| 1 Survey reference dates were: March 31, 2004-2006, March 30, 2007, and March 31, 2008. See Appendix A for changes in the survey base, methods, and instruments that affect analysis of trends over time. | ||||||||||
| SOURCE: Office of Applied Studies, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2004-2008. | ||||||||||